Patents Examined by Robert Kelly
  • Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide
    Patent number: 7393524
    Abstract: The invention relates to a genetically engineered baculovirus wherein said virus is engineered to target therapeutic agents to cells, typically cancer cells, for example prostate cancer cells.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: July 1, 2008
    Assignee: Procure Therapeutics Limited
    Inventor: Norman Maitland